PISANO, Calogera
 Distribuzione geografica
Continente #
NA - Nord America 6.168
AS - Asia 4.006
EU - Europa 3.463
SA - Sud America 723
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 14.487
Nazione #
US - Stati Uniti d'America 6.048
SG - Singapore 1.573
RU - Federazione Russa 1.214
CN - Cina 1.046
IT - Italia 620
BR - Brasile 578
HK - Hong Kong 363
VN - Vietnam 328
FI - Finlandia 323
PL - Polonia 292
DE - Germania 272
FR - Francia 202
GB - Regno Unito 144
BD - Bangladesh 133
JP - Giappone 109
IE - Irlanda 97
KR - Corea 85
UA - Ucraina 83
IN - India 82
AR - Argentina 43
RO - Romania 42
CA - Canada 41
MX - Messico 41
SE - Svezia 40
TR - Turchia 39
IQ - Iraq 37
NL - Olanda 32
SA - Arabia Saudita 31
ID - Indonesia 25
ZA - Sudafrica 25
EC - Ecuador 24
PK - Pakistan 24
VE - Venezuela 19
CO - Colombia 18
AT - Austria 17
BE - Belgio 17
ES - Italia 17
CI - Costa d'Avorio 16
UZ - Uzbekistan 16
KE - Kenya 15
MA - Marocco 15
NP - Nepal 15
MY - Malesia 12
PH - Filippine 12
PY - Paraguay 12
CL - Cile 11
EG - Egitto 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
AZ - Azerbaigian 8
IR - Iran 8
UY - Uruguay 8
DZ - Algeria 7
EU - Europa 7
JM - Giamaica 7
AU - Australia 6
GR - Grecia 6
MT - Malta 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AL - Albania 5
BG - Bulgaria 5
HN - Honduras 5
BH - Bahrain 4
BY - Bielorussia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
LB - Libano 4
NG - Nigeria 4
PE - Perù 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
ET - Etiopia 3
GE - Georgia 3
GY - Guiana 3
IL - Israele 3
LT - Lituania 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BN - Brunei Darussalam 2
CY - Cipro 2
DK - Danimarca 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LK - Sri Lanka 2
TG - Togo 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
Totale 14.471
Città #
Singapore 1.100
Ashburn 816
Fairfield 520
San Jose 487
Hong Kong 358
Chandler 343
Woodbridge 279
Zgierz 276
Council Bluffs 251
Houston 241
Wilmington 233
Seattle 219
Moscow 190
Hefei 181
Cambridge 180
Ann Arbor 169
Santa Clara 149
Beijing 140
Palermo 130
Lauterbourg 122
Tokyo 107
Los Angeles 103
Ho Chi Minh City 99
Dublin 97
Dallas 92
New York 92
Helsinki 84
Hanoi 83
Des Moines 82
Medford 80
Buffalo 61
Rome 60
São Paulo 55
Dearborn 53
Altamura 50
Princeton 49
Chicago 44
Frankfurt am Main 44
Guangzhou 44
Nanjing 44
The Dalles 42
Boardman 41
Jacksonville 36
Redondo Beach 36
Nuremberg 35
San Diego 35
Milan 34
Lawrence 33
Columbus 31
London 29
Piscataway 27
Shenyang 26
Atlanta 24
Riyadh 23
Phoenix 22
Orem 19
Tulsa 19
Munich 17
Abidjan 16
Brussels 16
Denver 16
Lappeenranta 16
Bologna 15
Chennai 15
Falls Church 15
Jinan 15
Mumbai 15
Rio de Janeiro 15
Belo Horizonte 14
Changsha 14
Da Nang 14
Haiphong 14
Montreal 14
Nairobi 14
Paris 14
Salt Lake City 14
Seoul 14
Tashkent 14
Xi'an 14
Baghdad 13
Brooklyn 13
Nanchang 13
Ningbo 13
Ludwigshafen am Rhein 12
Tianjin 12
Curitiba 11
Hải Dương 11
Warsaw 11
Ankara 10
Hebei 10
Jiaxing 10
Johannesburg 10
Shanghai 10
Vienna 10
Zhengzhou 10
Naples 9
Poplar 9
Quito 9
Redwood City 9
Venice 9
Totale 8.868
Nome #
Can the TLR-4-Mediated Signaling Pathway Be a Key Inflammatory Promoter for Sporadic TAA? 265
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals? 261
A particular phenotype of ascending aorta aneurysms as precursor of type A aortic dissection 256
Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives 253
THE ROLE OF INFLAMMATION IN TYPE A AORTIC DISSECTION: A PILOT STUDY 239
Histological and genetic studies in patients with bicuspid aortic valve and ascending aorta complications 237
OBTAINING MESENCHYMAL STEM CELLS FROM ADIPOSE TISSUE OR MURIN ORIGIN: EXPERIMENTAL STUDY. 235
Deregulation of Notch1 pathway and circulating endothelial progenitor cell (EPC) number in patients with bicuspid aortic valve with and without ascending aorta aneurysm 235
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. 235
Associations of rs3918242 and rs2285053 MMP-9 and MMP-2 polymorphisms with the risk, severity, and short- and long-term complications of degenerative mitral valve diseases: A 4.8-year prospective cohort study 233
Penn classification in acute aortic dissection patients 231
Cardiovascular disease in ageing: An overview on thoracic aortic aneurysm as an emerging inflammatory disease 230
Is the mean blood leukocyte telomere length a predictor for sporadic thoracic aortic aneurysm? Data from a preliminary study 229
Identification of Three Particular Morphological Phenotypes in Sporadic Thoracic Aortic Aneurysm: Phenotype III As Sporadic Thoracic Aortic Aneurysm biomarker in Aged Individuals 226
A Typical Immune T/B Subset Profile Characterizes Bicuspid Aortic Valve: In an Old Status? 217
Coronary artery fistulas: symptoms may not correlate to size. An emblematic case and literature review 216
Early structural degeneration of Mitroflow aortic valve: Another issue in addition to the mismatch? 211
Role of Matrix Metalloproteinases in complications of thoracic aortic aneurysm 209
Ascending aorta phenotypic and genotypic changes in bicuspid aortic valve disease 193
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. 188
Role of TGF-β pathway polymorphisms in sporadic thoracic aortic aneurysm: rs900 TGF-β2 is a marker of differential gender susceptibility. 186
Decellularized Saphena: Biologic Scaffold for 3D Cellular Growth 186
Impact of Prosthesis-Patient Mismatch after Mitral Valve Replacement 183
Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome 182
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 180
Regulation of PDE5 expression in human aorta and thoracic aortic aneurysms 175
Is the sporadic thoracic aneurysm the result of inflammatory process 168
Role of cachexia and fragility in the patient candidate for cardiac surgery 168
Focus on the unique mechanisms involved in thoracic aortic aneurysm formation in bicuspid aortic valve vs tricuspid aortic valve patients: clinical implications of a pilot study 167
CAN THE AORTIC WALL COMMUNICATE WITH US? 167
Biomechanical properties and histomorphometric features of aortic tissue in patients with or without bicuspid aortic valve 164
Vascular Aging effect on Medial aorta degeneration: focus on blood keukocyte telomere lenght in Hypertensive and old patients with sporadic thoracic aortic aneurysm 155
Is the Serum N Terminal Pro-Brain Natriuretic Peptide the Best Candidate Biomarker for Long-term Prognosis in Patients with Prosthesis-patient Mismatch after Mitral Valve Replacement? 155
Can The Aortic Wall Comunicate With Us? 153
Red Blood Cell Distribution Width, Vascular Aging Biomarkers, and Endothelial Progenitor Cells for Predicting Vascular Aging and Diagnosing/Prognosing Age-Related Degenerative Arterial Diseases 151
Diagnostic and Prognostic Relevance of Red Blood Cell Distribution Width for Vascular Aging and Cardiovascular Diseases 150
Stem cells and new intervention measures as emerging therapy in cardiac surgery 144
A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide 144
Pathophysiological implications of inflammation and genetic inflammatory factors in hypertensive and old patients affected by sporadic thoracic aortic aneurysm 141
TGF-B pathway polymorphisms as markers for gender differential susceptibility to sporadic thoracic aortic aneurysm 140
Notch 1 pathway and EPCs in bicuspid aortic valve: is their interplay involved in the ascending aortic aneurysm onset? 139
valve prosthesis-patient mismatch: hemodynamic, echocardiografic and clinical evidences 137
Immunohistochemical expression and apoptotic role of Caspase9 in aortic aneurysms 135
A Narrative Review: Syndecans in Aortic Aneurysm Pathogenesis and Course—Biomarkers and Targets? 118
Matrix Metalloproteinases (MMPs), Their Genetic Variants and miRNA in Mitral Valve Diseases: Potential Biomarker Tools and Targets for Personalized Treatments 115
RED BLOOD CELL DISTRIBUTION WIDTH PREDICTS MORBIDITY AND MORTALITY AFTER AORTIC VALVE REPLACEMENT 114
Retention of temporary epicardial pacing wires: when migration causes dehiscence of a sternal wound 111
Type 5 phosphodiesterase (PDE5) and the vascular tree: From embryogenesis to aging and disease 111
Acute type A aortic dissection: Beyond the diameter 105
Acute Myocardial Infarction Ten Days after Bentall Procedure due to Coronary Embolism: Etiology Discussion and Rare Case Presentation 105
Medial tunica degeneration of the ascending aortic wall is associated with specific microRNA changes in bicuspid aortic valve disease 100
Genotyping strategy of SMAD-3 rs3825977 gene variant for a differential management of ascending aorta aneurysm in women people: Gender oriented diagnostic tools 98
Oxidative Stress in the Pathogenesis of Aorta Diseases as a Source of Potential Biomarkers and Therapeutic Targets, with a Particular Focus on Ascending Aorta Aneurysms 98
Role of the inducibile nitric oxide synthase in inflammatory pathogenesis of the ascending aortic aneurysm 97
Risk of aortic dissection in patients with ascending aorta aneurysm: a new biological, morphological, and biomechanical network behind the aortic diameter 95
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 94
Polymorphisms of pro-inflammatory IL-6 and IL-1β cytokines in ascending aortic aneurysms as genetic modifiers and predictive and prognostic biomarkers 94
Hydrodynamic Alterations Produced by Subaortic Membranes: An in Vitro Study 92
The effect of preoperative respiratory physiotherapy and motor exercise in patients undergoing elective cardiac surgery: Short-term results 91
CAR, mGPS and hs-mGPS: What is among them the best gero-biomarker for age-related diseases? And for what clinical application? 90
Corrigendum to “CAR, mGPS and hs-mGPS: Which of these is the best gero-biomarker for age-related diseases? And for what clinical application?” [Mech. Aging Dev. 220 (2024) 111952] 90
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT Registry 89
Surgical "elephant trunk" arch replacement with a branched arch prosthesis: two alternative operative techniques 89
Pulmonary artery aneurysm: case report and experience of our center 88
Advantages of minimal access versus conventional aortic valve replacement in elderly or severely obese patients 88
1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: Results from the Italian OBSERVANT study 87
A rare localization of papillary fibroelastoma 82
A mathematical model to evaluate hemodynamic effects of the graft anastomosis in coronary surgery 80
Bentall Operation: Early Surgical Results, Seven-Year Outcomes, and Risk Factors Analysis 80
Mitral Valve Surgery by Means of Minimally Invasive Right Mini-Thoracotomy Compared with Standard Sternotomy: Technical Surgical Aspects, Clinical Results in the Current Era 80
Alternative surgical approach to repairing a giant sinus of valsalva aneurysm 80
miRNA Regulation of Cell Phenotype and Parietal Remodeling in Atherosclerotic and Non-Atherosclerotic Aortic Aneurysms: Differences and Similarities 79
Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding 79
Casistica 79
miRNA-Driven Regulation of Endothelial-to-Mesenchymal Transition Differs among Thoracic Aortic Aneurysms 79
The endoclamp device as a useful strategy during redo surgery on the aortic root and arch 79
Clinical outcome and hemodynamic performance of st. Jude trifecta aortic prosthesis: Short-term follow-up and risk factors analysis 78
Sutureless Aortic Prosthesis Valves versus Transcatheter Aortic Valve Implantation in Intermediate Risk Patients with Severe Aortic Stenosis: A Literature Review 76
CRT-723 Is the Sporadic Thoracic Aortic Aneurysm the Result of an Inflammatory Process? 75
Aspetti istomorfologici e genetici degli aneurismi 75
Analysis of the ice front propagation in heart tissues: First results 75
[Surgical and percutaneous treatment of hypertrophic obstructive cardiomyopathy: state-of-the-art review] 73
How Refined Surgical Technical Solutions Can Make Bentall Operation a Low-Risk Procedure: 20-Year Personal Experience at the “Root” of the Aortic Diseases—It Is Time to Change Surgical Guidelines 73
Red blood cell distribution width predicts mortality after coronary artery bypass grafting 73
The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery 72
Anaortic off-pump coronary artery surgery as a primary strategy to reduce the risk of neurological complications 72
Marfan syndrome in children: correlation between musculoskeletal features and cardiac Z-score 72
Biomarkers in Heart Failure: A Review and a Wish 72
The Endothelial Transcription Factor ERG Mediates a Differential Role in the Aneurysmatic Ascending Aorta with Bicuspid or Tricuspid Aorta Valve: A Preliminary Study 71
miR-632 Induces DNAJB6 Inhibition Stimulating Endothelial-to-Mesenchymal Transition and Fibrosis in Marfan Syndrome Aortopathy 69
The need for the STS Score risk stratification system for aortic root aneurysms surgery 68
Perceval sutureless bioprosthesis versus Trifecta sutured bioprosthesis for aortic valve replacement: immediate results of the Perfecta study 67
Warm blood versus St. Thomas cardioplegia for myocardial protection in patients undergoing coronary artery bypass grafting 67
Early-Staged Carotid Artery Stenting Prior to Coronary Artery Bypass Grafting: Analysis of the Early and Mid-Term Results in Comparison with a Consecutive Cohort of Isolated Coronary Artery Surgery Patients 66
Imaging and monitoring in minimally invasive valve surgery using an intra-aortic occlusion device: A single center experience 66
The Role of the Patient-Prosthesis Mismatch after Aortic Valve Replacement: The Prognostic Significance 66
Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population: Final Results from the OBSERVANT Study 65
Cerebrovascular events after cardiovascular surgery: diagnosis, management and prevention strategies 65
Eicosanoids and aneurysms 64
Numerical simulations of temperature inside the heart tissues to evaluate the performances of cryoablative probe 64
Totale 13.009
Categoria #
all - tutte 56.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 0 57 72
2021/2022640 42 113 32 19 21 32 36 45 79 64 39 118
2022/2023927 104 159 28 103 95 141 60 78 104 1 44 10
2023/20241.057 16 57 11 34 25 70 34 89 5 400 202 114
2024/20252.423 93 273 214 175 76 84 151 116 210 228 288 515
2025/20267.043 522 208 648 560 588 983 1.152 775 614 615 378 0
Totale 15.219